The Midland County Health and Human Services Council hosted an annual panel Wednesday morning at Midland City Hall to discuss the Community Health Improvement Plan for 2025. The panel, moderated by ...
The unprecedented increase in drug overdose deaths in the U.S., long believed to be driven by access to legal and illegal ...
Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid addiction ...
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, ...
Texas and 14 other states have secured a $7.4 billion settlement from the Sackler family and their company, Purdue Pharma, for their roles in creating the opioid crisis. Purdue Pharma was the ...
The deal, announced Thursday, removes non-consensual releases to the Sackler family, Purdue's founders, which the U.S. Supreme Court had invalidated last year.
Walgreens has long been a leader in providing education and resources, as well as implementing best-in-class policies and procedures, to help combat opioid misuse and abuse." Walgreens added that ...
(2)Approximately 40 million Americans with acute pain are prescribed an opioid to manage th PALO ALTO ... potential best-in-class novel oral tablet, KDS2010, for the treatment of obesity and ...
The Sackler family and Purdue Pharma have agreed to pay $7.4 billion to resolve nationwide opioid litigation, marking a major milestone in efforts to hold the makers of the addictive pain medication ...
In an election year, Poilievre's Conservatives need to do everything they can to distance themselves from the ruling left. A ...
Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...